Fluticasone Furoate/Umeclidinium Bromide

糠酸氟替卡松/芜地溴铵

Report date: 2025/11/14 13:58:50

Base Information

Drug NameFluticasone Furoate/Umeclidinium Bromide
Drug Alias NameFluticasone Furoate+Umeclidinium Bromide糠酸氟替卡松•芜地溴铵糠酸氟替卡松-芜地溴铵Umeclidinium/Fluticasone FuroateFluticasone Furoate/Umeclidinium +[13] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionMuscarinic acetylcholine receptor M1 antagonistsMuscarinic acetylcholine receptor M5 antagonistsGlucocorticoid receptor agonists +[6] 
TargetsGlucocorticoid receptorMuscarinic acetylcholine receptor M2Muscarinic acetylcholine receptor M1 +[6] 
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesThailandRussian Federation +[5] 
CombinationsYes Fluticasone FuroateUmeclidinium Bromide
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A